伊人久久大香线蕉AV影院,情侣国产一二三区视频观看,香蕉丝瓜榴莲在线观看√天堂资源中文官网,日韩精品无码观看视频免费,亚洲伊人成无码综合网欧美亚洲综合在线一区,国产午夜精品视频一区二区三区,亚洲毛片在线日韩无码大乱交,国产精品国产三级欧美二区

Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire industry chain, has recently been included in the FTSE Russell Global Equity Index Series.

FTSE Russell is a globally renowned index provider, whose index products cover markets in more than 70 countries and regions, with approximately $20 trillion in assets benchmarked against FTSE Russell index products.

Hu Huiguo, Director, Senior Vice President, and Board Secretary of Mabwell, said: “Being included in the FTSE Russell Global Equity Index Series indicates market's ongoing recognition of Mabwell's operational performance, stock liquidity, and development potential. Mabwell will continue to commit to the research and commercialization of innovative drugs, and actively promote the globalization of the value of innovative products, benefiting more patients worldwide, thereby realizing the potential and goals for long-term sustainable growth, and creating more value for shareholders and society.”